Arcus Biosciences, Inc. - Common Stock (RCUS)

CUSIP: 03969F109

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock
Shares outstanding
122,470,452
Total 13F shares
48,251,727
Share change
+1,613,195
Total reported value
$1,682,950,642
Put/Call ratio
26%
Price per share
$34.87
Number of holders
127
Value change
+$59,932,851
Number of buys
49
Number of sells
62

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 03969F109?
CUSIP 03969F109 identifies RCUS - Arcus Biosciences, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Alphabet Inc.
13F
Company
3.8%
4,613,818
$126,695,000 30 Jun 2021
13F
BlackRock Finance, Inc.
13F
Company
3.3%
4,038,728
$110,902,000 30 Jun 2021
13F
PFM Health Sciences, LP
13F
Company
2.9%
3,498,260
$96,062,000 30 Jun 2021
13F
EcoR1 Capital, LLC
13F
Company
2.7%
3,335,247
$91,586,000 30 Jun 2021
13F
FMR LLC
13F
Company
2.5%
3,091,165
$84,883,000 30 Jun 2021
13F
BVF INC/IL
13F
Company
2.3%
2,797,822
$76,828,000 30 Jun 2021
13F
STATE STREET CORP
13F
Company
2.2%
2,685,701
$73,749,000 30 Jun 2021
13F
VANGUARD GROUP INC
13F
Company
2%
2,466,442
$67,730,000 30 Jun 2021
13F
Boxer Capital, LLC
13F
Company
1.7%
2,084,883
$57,251,000 30 Jun 2021
13F
Invus Financial Advisors, LLC
13F
Company
1.5%
1,842,077
$50,583,000 30 Jun 2021
13F
Woodline Partners LP
13F
Company
1.4%
1,663,568
$45,682,000 30 Jun 2021
13F
FRANKLIN RESOURCES INC
13F
Company
0.72%
876,038
$24,056,000 30 Jun 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.63%
771,554
$21,186,000 30 Jun 2021
13F
Octagon Capital Advisors LP
13F
Company
0.62%
760,164
$20,874,000 30 Jun 2021
13F
TimesSquare Capital Management, LLC
13F
Company
0.56%
687,540
$18,880,000 30 Jun 2021
13F
SECTORAL ASSET MANAGEMENT INC
13F
Company
0.55%
674,260
$18,515,000 30 Jun 2021
13F
NORTHERN TRUST CORP
13F
Company
0.55%
668,181
$18,348,000 30 Jun 2021
13F
MACQUARIE GROUP LTD
13F
Company
0.38%
463,398
$12,725,000 30 Jun 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.35%
425,074
$11,673,000 30 Jun 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.34%
416,731
$11,444,000 30 Jun 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.31%
376,500
$10,339,000 30 Jun 2021
13F
D. E. Shaw & Co., Inc.
13F
Company
0.29%
354,946
$9,746,000 30 Jun 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.28%
344,559
$9,462,000 30 Jun 2021
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.25%
311,796
$8,562,000 30 Jun 2021
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.24%
298,410
$8,195,000 30 Jun 2021
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.24%
297,088
$8,158,000 30 Jun 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.23%
275,700
$7,571,000 30 Jun 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.22%
273,733
$7,517,000 30 Jun 2021
13F
MORGAN STANLEY
13F
Company
0.22%
269,458
$7,399,000 30 Jun 2021
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.22%
268,711
$7,379,000 30 Jun 2021
13F
Parkman Healthcare Partners LLC
13F
Company
0.2%
246,637
$6,773,000 30 Jun 2021
13F
DEUTSCHE BANK AG\
13F
Company
0.19%
232,138
$6,375,000 30 Jun 2021
13F
Invesco Ltd.
13F
Company
0.18%
218,353
$5,997,000 30 Jun 2021
13F
Bank of New York Mellon Corp
13F
Company
0.17%
203,411
$5,586,000 30 Jun 2021
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.15%
189,454
$5,202,000 30 Jun 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.14%
172,732
$4,743,000 30 Jun 2021
13F
CITIGROUP INC
13F
Company
0.13%
163,269
$4,483,000 30 Jun 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.11%
137,752
$3,783,000 30 Jun 2021
13F
DAFNA Capital Management LLC
13F
Company
0.1%
119,700
$3,287,000 30 Jun 2021
13F
Rafferty Asset Management, LLC
13F
Company
0.09%
104,799
$2,878,000 30 Jun 2021
13F
FIRST TRUST ADVISORS LP
13F
Company
0.09%
104,578
$2,872,000 30 Jun 2021
13F
PARK CIRCLE Co
13F
Company
0.08%
100,000
$2,746,000 30 Jun 2021
13F
ALPS ADVISORS INC
13F
Company
0.08%
93,506
$2,568,000 30 Jun 2021
13F
Walleye Capital LLC
13F
Company
0.07%
86,438
$2,374,000 30 Jun 2021
13F
Swiss National Bank
13F
Company
0.07%
85,896
$2,359,000 30 Jun 2021
13F
Parallel Advisors, LLC
13F
Company
0.07%
85,225
$2,340,000 30 Jun 2021
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
0.06%
75,290
$2,067,000 30 Jun 2021
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.06%
75,000
$2,060,000 30 Jun 2021
13F
Bellevue Group AG
13F
Company
0.06%
75,000
$2,060,000 30 Jun 2021
13F
Alpha Paradigm Partners, LLC
13F
Company
0.06%
71,951
$1,976,000 30 Jun 2021
13F

Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q3 2021

As of 30 Sep 2021, Arcus Biosciences, Inc. - Common Stock (RCUS) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,251,727 shares. The largest 10 holders included EcoR1 Capital, LLC, BlackRock Inc., Alphabet Inc., PFM Health Sciences, LP, BVF INC/IL, FMR LLC, VANGUARD GROUP INC, STATE STREET CORP, BOXER CAPITAL, LLC, and Invus Financial Advisors, LLC. This page lists 127 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
125
Q3 2021 holders
127
Holder diff
2
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 Value $ Q3 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.